Secondary analysis. September 15, 2023 - september 14, 2026. N01DA-22-2253. Task order no. 75N95023F00012 (TO16)
Ended Awarded Last action
- Contract number
- 75N95023F00012
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $754,669
Award facts
- Contract value 100% obligated
- $754,669.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Original award | $754,669 |
About this award
This is a $754,669.00 cost-plus-fixed-fee delivery order awarded to The Emmes Company LLC by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The contract is for secondary analysis services from September 15, 2023 to September 14, 2026 under NIDA's DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER program. This is not a set-aside contract. The Emmes Company is a global clinical research organization that provides comprehensive research support services to federal agencies, particularly NIH institutes. The company has extensive experience managing clinical trials and data coordination for substance abuse, infectious disease, genomic, and public health research initiatives through various NIH contract and grant awards.
Quick answers
Who was awarded contract 75N95023F00012?
75N95023F00012 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2023.
How much is contract 75N95023F00012 worth?
The government has obligated $754,669 on 75N95023F00012.
Is contract 75N95023F00012 an order under another contract?
Yes. 75N95023F00012 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95023F00012 competed?
The extent of competition for 75N95023F00012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award